GC answer to Freegriff MANF patent question: G
Post# of 30028
(Total Views: 498)
Posted On: 01/30/2018 11:07:35 AM
GC answer to Freegriff MANF patent question:
Gerald Commissiong
@G_Commish
Following Following @G_Commish
More
Replying to @FREE6RIFF
$AMBS owns patent app https://patents.google.com/patent/US20110212055A1/en … covering MANF for PD delivered to substantia nigra, where data show most likely benefit. $AMBS priority date (3/25/08) precedes Herantis (4/30/08) https://www.google.com/patents/US9592270 … . Hope this answers lingering questions. $AMBS MANF IP leader
https://patents.google.com/patent/US20110212055A1/en
https://www.google.com/patents/US9592270
Gerald Commissiong
@G_Commish
31m31 minutes ago
More
With respect to NovoDerm, $AMBS has a right to license it at any time until the 5th anniversary of the transaction (late 2019) per the agreement. https://www.sec.gov/Archives/edgar/data/14248...587_8k.htm …
Gerald Commissiong
@G_Commish
Following Following @G_Commish
More
Replying to @FREE6RIFF
$AMBS owns patent app https://patents.google.com/patent/US20110212055A1/en … covering MANF for PD delivered to substantia nigra, where data show most likely benefit. $AMBS priority date (3/25/08) precedes Herantis (4/30/08) https://www.google.com/patents/US9592270 … . Hope this answers lingering questions. $AMBS MANF IP leader
https://patents.google.com/patent/US20110212055A1/en
https://www.google.com/patents/US9592270
Gerald Commissiong
@G_Commish
31m31 minutes ago
More
With respect to NovoDerm, $AMBS has a right to license it at any time until the 5th anniversary of the transaction (late 2019) per the agreement. https://www.sec.gov/Archives/edgar/data/14248...587_8k.htm …
(6)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼